INFORMATION AND SERVICES EXCLUSIVELY FOR US HEALTHCARE PROFESSIONALS

Severe allergic reaction (eg, anaphylaxis) after a previous dose of any diphtheria toxoid-, tetanus toxoid-, pertussis-, hepatitis B-, or poliovirus-containing vaccine or to any component of PEDIARIX is a contraindication for PEDIARIX

...continue reading

Since 2002, PEDIARIX has been the cornerstone of GSK’s
DTaP-containing vaccine portfolio.*

PEDIARIX, first made available in 2002, has been used in appropriate pediatric patients 6 weeks of age through 6 years of age (prior to the 7th birthday).

DTaP=diphtheria, tetanus, and acellular pertussis.
*GSK DTaP-containing vaccines are to be administered according to their approved indications.

Learn more about the GSK portfolio of DTaP-containing vaccines

Learn more about INFANRIX Learn more about KINRIX

713083R0 July 2016